BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9037021)

  • 1. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer.
    Tacke R; Chen Y; Manley JL
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1148-53. PubMed ID: 9037021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
    Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
    J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
    Tacke R; Manley JL
    EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.
    Xiao SH; Manley JL
    Genes Dev; 1997 Feb; 11(3):334-44. PubMed ID: 9030686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Liu X; Mayeda A; Tao M; Zheng ZM
    J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
    Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
    EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
    Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
    EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
    Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
    PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear export and retention signals in the RS domain of SR proteins.
    Cazalla D; Zhu J; Manche L; Huber E; Krainer AR; Cáceres JF
    Mol Cell Biol; 2002 Oct; 22(19):6871-82. PubMed ID: 12215544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.
    Liu HX; Chew SL; Cartegni L; Zhang MQ; Krainer AR
    Mol Cell Biol; 2000 Feb; 20(3):1063-71. PubMed ID: 10629063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-mRNA splicing in the absence of an SR protein RS domain.
    Zhu J; Krainer AR
    Genes Dev; 2000 Dec; 14(24):3166-78. PubMed ID: 11124808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.
    Xiao SH; Manley JL
    EMBO J; 1998 Nov; 17(21):6359-67. PubMed ID: 9799243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
    Li X; Shambaugh ME; Rottman FM; Bokar JA
    RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer.
    Yeakley JM; Morfin JP; Rosenfeld MG; Fu XD
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7582-7. PubMed ID: 8755518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
    Cao W; Jamison SF; Garcia-Blanco MA
    RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1.
    Ma CT; Ghosh G; Fu XD; Adams JA
    J Mol Biol; 2010 Oct; 403(3):386-404. PubMed ID: 20826166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.